Filing Details
- Accession Number:
- 0001562180-22-003739
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-04 16:33:02
- Reporting Period:
- 2022-05-02
- Accepted Time:
- 2022-05-04 16:33:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1531048 | Inari Medical Inc. | NARI | Surgical & Medical Instruments & Apparatus (3841) | 452902923 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1806431 | Andrew Hykes | C/O Inari Medical, Inc. 6001 Oak Canyon, Suite 100 Irvine CA 92618 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-05-02 | 200 | $77.14 | 155,366 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-02 | 1,418 | $78.76 | 155,566 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-02 | 2,119 | $79.80 | 153,247 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-02 | 1,163 | $80.80 | 152,084 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-02 | 100 | $81.75 | 151,984 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,550 | Indirect | By Child 1 |
| Common Stock | 1,550 | Indirect | By Child 2 |
| Common Stock | 1,550 | Indirect | By Child 3 |
| Common Stock | 1,000 | Indirect | By Spouse |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2021.
- This transaction was executed in multiple trades at prices ranging from $77.11 to $77.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $78.36 to $79.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $79.36 to $80.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $80.43 to $81.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
